Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoviCompareM: mRNA-1273 Immunogenicity in Older vs Younger Adults
NCT04748471Phase 2Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2021
- Primary completion
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
01
Overview
A Phase 2 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04748471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748471.